How GLP-1 Receptor Agonists Evolved from Diabetes to Weight Loss Treatments
1:00:31
AI-First Drug Design: Accelerating the Discovery of New Therapeutics
59:52
A Med Chemist's Guide to Formulation Options to Improve Oral Bioavailability
47:52
What is GLP-1, What Does It Do, and Where Does It Come From? with Dr. Ben Bikman
28:17
Chronic Kidney Disease and GLP-1 RAs
48:12
EFL021 - Metabolic Effects of a Dual GIP and GLP-1 RA
58:16
The Increasing Importance of GLP-1–Based Therapies for Personalized Obesity Management
1:02:37
The Chemist's Playbook: Impactful Bioisosteres for Modern Drug Design
50:48